SGLT2 inhibition slows tumor growth in mice by reversing hyperinsulinemia

BACKGROUND: Obesity confers an increased risk and accelerates the progression of multiple tumor types in rodents and humans, including both breast and colon cancer. Because sustained weight loss is rarely achieved, therapeutic approaches to slow or prevent obesity-associated cancer development have...

Descripción completa

Detalles Bibliográficos
Autores principales: Nasiri, Ali R., Rodrigues, Marcos R., Li, Zongyu, Leitner, Brooks P., Perry, Rachel J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6907191/
https://www.ncbi.nlm.nih.gov/pubmed/31867105
http://dx.doi.org/10.1186/s40170-019-0203-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6907191/
https://www.ncbi.nlm.nih.gov/pubmed/31867105
http://dx.doi.org/10.1186/s40170-019-0203-1

Ejemplares similares